Skip to main navigation Skip to search Skip to main content

Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis

  • Gitte Berkers
  • , Peter van Mourik
  • , Annelotte M. Vonk
  • , Evelien Kruisselbrink
  • , Johanna F. Dekkers
  • , Karin M. de Winter-de Groot
  • , Hubertus G.M. Arets
  • , Rozemarijn E.P. Marck-van der Wilt
  • , Jasper S. Dijkema
  • , Maaike M. Vanderschuren
  • , Roderick H.J. Houwen
  • , Harry G.M. Heijerman
  • , Eduard A. van de Graaf
  • , Sjoerd G. Elias
  • , Christof J. Majoor
  • , Gerard H. Koppelman
  • , Jolt Roukema
  • , Marleen Bakker
  • , Hettie M. Janssens
  • , Renske van der Meer
  • Robert G.J. Vries, Hans C. Clevers, Hugo R. de Jonge, Jeffrey M. Beekman, Cornelis K. van der Ent

Research output: Contribution to journalArticlepeer-review

266 Citations (Scopus)

Abstract

Berkers et al. demonstrate that stem cell cultures (organoids) can be a tool for personalized medicine. They show a high correlation between in vitro and in vivo effects of drugs and demonstrate good-to-excellent predictive values of the organoid test for preclinical identification of responders to CFTR modulators.

Original languageEnglish
Pages (from-to)1701-1708.e3
JournalCell reports
Volume26
Issue number7
DOIs
Publication statusPublished - 12 Feb 2019
Externally publishedYes

Keywords

  • CFTR
  • cystic fibrosis
  • drug response
  • organoids
  • personalized treatment
  • predicting
  • stem cell cultures

Fingerprint

Dive into the research topics of 'Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis'. Together they form a unique fingerprint.

Cite this